// App-Quantinova.ai

676 : Tissue inhibitor of metalloproteinase-2 (TIMP2) deficiency enhances tumor burden via increasing HIF-2a expression

Researchers

Presenter

  • Sarvesh Kumar

Principal Investigators

  • Sandra M. Jensen

  • Ananda Chowdhury

  • Beiyang Wei

  • William G. Stetler-Stevenson

Medical Centers

  • ATCC, Gaithersburg, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Lewis lung carcinoma

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Cluster of Differentiation 31

  • Kinase Insert Domain Receptor

  • TIMP Metallopeptidase Inhibitor 2

  • Vascular endothelial growth factor A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved